A retrospective analysis of early medicine access in Spain suggests regulatory changes to improve equity.
Until legislation regulates access to medicines awaiting reimbursement, or decision times are reduced, implementing robust local procedures is essential to guarantee fair and equitable MSS access, particularly for patients requiring treatment before national PR resolution.
No takes yet. Share an insight, caveat, or question.
Porcel‐Maleno et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: